Lenalidomide 5mg Capsule (Generic Revlimid® 5mg)

Lenalidomide 5mg Capsule contains 5mg lenalidomide, an oral immunomodulatory anticancer medicine used in approved hematology-oncology treatment protocols. Generic lenalidomide 5mg is marketed as an alternative to Revlimid® 5mg, with manufacturer and packaging varying by product. Local terminology includes Lenalidomid 5 mg, lénalidomide 5 mg, 레날리도마이드 5mg and леналидомид 5 мг. Current U.S. labeling documents 5mg capsules, while Australia, France, Germany, South Korea and Russia also document 5mg lenalidomide capsule products.

Product Information

• Generic Name: Lenalidomide
• Strength: 5mg
• Dosage Form: Hard Capsule
• Route: Oral
• Drug Class: Immunomodulatory Antineoplastic Agent
• Reference Brand: Revlimid® 5mg
• Therapeutic Area: Hematologic Oncology
• Prescription Status: Prescription medicine
• Manufacturer: Varies by product
• Pack Size: Varies by country and manufacturer

Main Uses

Lenalidomide is used in approved treatment regimens for multiple myeloma and selected hematologic conditions, including certain myelodysplastic syndromes and lymphoma indications depending on the local authorization. The 5mg strength may be used as part of an individualized regimen, including situations where dose adjustment is required.

Generic Revlimid® 5mg

Revlimid® is the reference medicine containing lenalidomide. Generic lenalidomide 5mg contains the same active ingredient but may differ in manufacturer, capsule markings, inactive ingredients and packaging.

France’s public medicines database currently identifies Lenalidomide Mylan 5mg as a generic and places it in the generic group corresponding to Revlimid 5mg.

Commercial Availability

High-intent searches around this strength include lenalidomide 5mg price, lenalidomide 5mg capsule, generic Revlimid 5mg, Revlimid 5mg capsule, lenalidomide 5mg cost, lenalidomide 5mg pharmacy and lenalidomide 5mg prescription.

Australia’s current PBS listing includes lenalidomide 5mg capsules in 21- and 28-capsule presentations, with Lenalide, Lenalidomide Dr.Reddy’s, Lenalidomide Sandoz and Revlimid listed as available brands.

Safety

Lenalidomide is a high-risk prescription oncology medicine. Important risks include embryo-fetal toxicity, reduced blood-cell counts and venous or arterial thromboembolic events. Restricted-distribution and pregnancy-prevention requirements apply in major markets. Patients should use lenalidomide only under appropriate oncology supervision.

Frequently Asked Questions

What is Lenalidomide 5mg used for?
Lenalidomide 5mg is used as part of approved treatment protocols for multiple myeloma and certain other hematologic cancers, depending on the local product indication.

Is Lenalidomide 5mg the generic version of Revlimid 5mg?
Yes. Revlimid® is the reference brand containing lenalidomide; generic lenalidomide products contain the same active ingredient.

Is Lenalidomide 5mg available as a capsule?
Yes. Current U.S., UK, Australian, European, Korean and Russian market information documents 5mg capsule presentations.

What pack sizes are available?
Pack sizes vary by market. Current examples include 21 and 28 capsules in Australia, while U.S. generic labeling includes 28-capsule presentations.

Is Lenalidomide 5mg prescription-only?
Yes. It is a prescription oncology medicine and additional risk-management requirements may apply.

Last Updated: September 27, 2026 | Medically Reviewed By: Licensed Pharmacist

Medical Disclaimer:
This information is for educational and product-identification purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Lenalidomide should be used only under appropriate specialist supervision.